Apollo Hospitals and Buddhi Clinic together with the International 2022
~An event to raise awareness
about Brain & Mind Health~
Apollo
Hospitals and Buddhi Clinic together with the International Neuropsychiatric
Association organies Neuropsychiatry Roundtable 2022. Especially post Covid many are experiencing a surge in
mental health conditions or mental disorders. The world needs to think
innovatively and improve the systems of care to meet the demand and provide the
best care for affected. This open forum is being organised to create awareness
about brain and mind health.
When we think of
neurology and psychiatry, we consider them as two distinct disciplines, as
different as chalk from cheese. For the clinical practitioner and indeed for
those working in community and public health, the two are not that different,
and there is a broad and considerable interface.
Click here to watch Video:
https://www.youtube.com/watch?v=vA6pQQMMlQ0
https://www.youtube.com/watch?v=yft9MOzI3q8
The 18th century practitioners and opinion leaders in
Europe did not consider neurology and psychiatry as distinct; European
neurologists for example described behaviour as an “epilepsy equivalent". Sigmund Freud, who started
his career as a neurologist, went on to develop his psychoanalytic theory of
emotional symptoms, which over time resulted in an expending schism between
neurology and psychiatry. The two specialties began to come together once again
with the advent of neuroscience in association with the development of
biological sciences and pharmacology. Drug development, brain imaging,
genetics, molecular biology and immunology have transformed our ability to
visualise what goes on in diseased brains. Today neurology and psychiatry share
a broad interface in clinical care, science and public health and this is what
The Neuropsychiatry Roundtable is focused on.
Professor Gagandeep Singh, President of the Indian
Academy of Neurology, said, “There is no doubt today that the links between the brain and mind are stronger
than ever before and that there is a broad interface between the disciplines of
neurology and psychiatry. People with cognitive, behavioural and disability
needs need collaboration between the specialties as well as multidisciplinary
care and support. In this context The Neuropsychiatry Roundtable organised
together with the International Neuropsychiatric Association gives opportunity
for such discussion and deliberation and will lead to substantive advancements
in clinical care.”
Professor Ennapadam S Krishnamoorthy, Founder- Buddhi
Clinic, Senior Clinical Advisor- Neurosciences, Apollo Hospitals and Past
President, International Neuropsychiatric Association highlighted, that, “The clinical and public health impact of
neurodegenerative disorders, prevalent in the elderly is increasing. The impact
of these conditions is both neurological and psychiatric with several general
medical co-morbidities like Diabetes, Hypertension, Obesity and High
Cholesterol being active contributors. These patients have orthopaedic,
cardiac, respiratory, gastro-intestinal and uro-gynaecological co-morbidities,
resulting in multi-specialty clinical needs and multi-disciplinary clinical
approaches. It is here that the diversity of therapy and rehabilitation,
blending modern science with the wisdom of healthcare traditions as practiced
in Buddhi Clinic becomes relevant. We hope to see these comprehensive
approaches to neuropsychiatry, elder care and chronic disease management,
mainstream themselves, and it is therefore appropriate that we are working
together with Apollo Hospitals, Asia’s premier
healthcare organisation to co-host this event.
Dr. Rohini Sridhar, Senior Vice President-
Medical Service for Hospital Division- Operations, Apollo Hospitals expressed
that, “Many specialists in neurology, psychiatry and rehabilitation including a
large number from the Apollo Hospitals group were actively participating in The
Neuropsychiatry Roundtable. We are excited about the prospect of mainstreaming
new comprehensive care models to address these important and unique needs.”
Experts in Neuropsychiatry outlined the clinical and
public health importance of this interface discipline, neuropsychiatry. Prof.
Valsamma Eapen, Professor of Child Psychiatry at the University of New South
Wales, Sydney, Australia and incoming President of the International
Neuropsychiatric Association spoke about the importance of childhood
neurodevelopmental disability and its impact across the lifespan. Putting focus
on autism and her extensive research and clinical experience, she pointed out
the lifelong needs that existed for specially designed clinical and
rehabilitation services in these sufferers. Professor Ludger T van Elst,
Professor of Neuropsychiatry at the University of Freiburg, Germany, talked out
how autoimmune diagnosis was changing the face of chronic mental health
conditions like schizophrenia. Many patients with autoimmune conditions,
presented with neuropsychiatric symptoms he said, requiring a different
clinical approach that had potential for symptom reversal and cure. The COVID
pandemic and neuropsychiatric symptoms in its context were a clear indication
of mental health and neurodisability caused due to infection and autoimmune
response. These highlighted the need for active interaction between medical,
neurological, psychiatric and rehabilitation specialists he said. Dr. Rema
Raghu, Chief Clinical Officer, Buddhi Clinic also spoke.
